We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$42.2B
AUM Growth
-$360M
(-0.85%)
Cap. Flow
-$2.32B
Cap. Flow
% of AUM
-5.5%
Top 10 Holdings %
Top 10 Hldgs %
7.6%
Holding
2,945
New
147
Increased
1,226
Reduced
1,320
Closed
236
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$859M |
| 2 |
Apple
AAPL
|
+$61.2M |
| 3 |
Norwegian Cruise Line
NCLH
|
+$56M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.7M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$106M |
| 2 |
ULQ
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
|
+$84.5M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$53.6M |
| 4 |
Applied Materials
AMAT
|
+$37.5M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.48% |
| 2 | Financials | 12.95% |
| 3 | Healthcare | 12.03% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Inseego
INSG
$120M
| $19K | ﹤0.01% |
1,207
-150
| -11% | -$2.33K |
|
|
NAVB
2677
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $18K | ﹤0.01% |
2,495
-311
| -11% | -$2.63K |
|
|
WG
2678
DELISTED
Willbros Group
WG
| $17K | ﹤0.01% |
12,275
-1,533
| -11% | -$3.21K |
|
2679
Tempest Therapeutics
TPST
$14M
| $16K | ﹤0.01% |
4
| – | – |
|
|
VVUS
2680
DELISTED
Vivus Inc
VVUS
| $15K | ﹤0.01% |
2,986
-372
| -11% | -$2.55K |
|
2681
Vaalco Energy
EGY
$564M
| $14K | ﹤0.01% |
20,262
-2,530
| -11% | -$1.98K |
|
2682
Harte-Hanks
HHS
$14.8M
| $14K | ﹤0.01% |
1,432
-179
| -11% | -$1.8K |
|
2683
Innodata
INOD
$2.07B
| $14K | ﹤0.01% |
10,367
-1,295
| -11% | -$1.55K |
|
2684
Veru
VERU
$36.3M
| $13K | ﹤0.01% |
1,108
-139
| -11% | -$1.97K |
|
2685
Microbot Medical
MBOT
$119M
| $12K | ﹤0.01% |
771
-96
| -11% | -$1.63K |
|
|
CGRN
2686
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $12K | ﹤0.01% |
1,548
-194
| -11% | -$1.73K |
|
|
RAS
2687
DELISTED
RAIT Financial Trust
RAS
| $11K | ﹤0.01% |
28,095
-3,510
| -11% | -$1.58K |
|
|
IPAS
2688
DELISTED
Ipass Inc Common Stock
IPAS
| $11K | ﹤0.01% |
2,110
-264
| -11% | -$1.61K |
|
2689
Orion Energy Systems
OESX
$41.5M
| $10K | ﹤0.01% |
1,189
-148
| -11% | -$1.36K |
|
|
VXRT
2690
DELISTED
Vaxart
VXRT
| $10K | ﹤0.01% |
1,633
-204
| -11% | -$1.43K |
|
|
RSYS
2691
DELISTED
Radisys Corp
RSYS
| $10K | ﹤0.01% |
10,206
-1,276
| -11% | -$1.36K |
|
|
BIOL
2692
DELISTED
Biolase, Inc.
BIOL
| $9K | ﹤0.01% |
2
| – | – |
|
|
CASM
2693
DELISTED
CAS Medical Systems, Inc.
CASM
| $9K | ﹤0.01% |
12,172
-1,520
| -11% | -$1.11K |
|
2694
United States Antimony
UAMY
$839M
| $8K | ﹤0.01% |
25,261
-3,154
| -11% | -$829 |
|
2695
Theriva Biologics
TOVX
$10.2M
| $7K | ﹤0.01% |
2
| – | – |
|
|
AUMN
2696
DELISTED
Golden Minerals Company
AUMN
| $7K | ﹤0.01% |
629
-79
| -11% | -$836 |
|
|
GMO
2697
DELISTED
General Moly, Inc.
GMO
| $7K | ﹤0.01% |
19,788
-2,471
| -11% | -$787 |
|
|
NLST
2698
DELISTED
Netlist, Inc.
NLST
| $7K | ﹤0.01% |
22,379
-2,795
| -11% | -$1.39K |
|
|
ESNC
2699
DELISTED
EnSync Inc
ESNC
| $7K | ﹤0.01% |
17,838
-2,228
| -11% | -$965 |
|
|
AIM
2700
AIM ImmunoTech
AIM
$7.32M
| $7K | ﹤0.01% |
4
-1
| -20% | -$1.44K |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
NMIFOAC
WANY
ACA
Guggenheim Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Guggenheim Capital held 2,945 positions worth $42.2B, down 0.85% from $42.6B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
Guggenheim Capital withdrew a net $2.32B in Q4 2017, closing 236 positions and reducing 1,320 holdings. Its most notable exit was CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF, an estimated $84.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Guggenheim Capital opened a new position in iShares China Large-Cap ETF worth $18M.
- Guggenheim Capital's largest Q4 2017 buy was iShares China Large-Cap ETF: 389,755 shares worth $18M.
- Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, an estimated $859M increase.
- Guggenheim Capital's biggest Q4 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $106M.
- Guggenheim Capital fully exited CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF in Q4 2017, selling an estimated $84.5M.
- Guggenheim Capital's ten largest holdings make up 7.6% of its $42.2B portfolio in Q4 2017.
- Guggenheim Capital opened 147 new positions and closed 236 in Q4 2017.
- Guggenheim Capital's portfolio value fell 0.85% quarter-over-quarter to $42.2B.
Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.